Executives
-
Johnson Rady AExecutive Vice President -
Bourla AlbertChairman & CEO
-
Fonseca LidiaExecutive Vice President
-
Denton David MChief Financial Officer & EVP
-
Mcdermott MichaelExecutive Vice President
-
Dolsten MikaelPresident R&D
-
Susman SallyExecutive Vice President
-
Malik AamirExecutive Vice President
-
Sahni PayalExecutive Vice President
-
Lankler Douglas MExecutive Vice President
-
Damico Jennifer B.SVP & Controller
-
Baum AndrewExecutive Vice President
-
Boshoff ChristoffelExecutive Vice President
-
De Germay AlexandreExecutive Vice President
?
Mcdermott Michael
Executive Vice President
Pfizer Inc.
US, New York [HQ]
CIK
1902464
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
954,080,000
Price per Share :
$26.49
Equivalence :
$25,273,579,200.00
Transaction History
-
M954,080,000 Shares After TransactionValue : $26,084,547,200.00$3,393,440,800.00Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.#5 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).#6 Price is the closing price of Pfizer common stock on February 23, 2024.
-
F945,490,000 Shares After TransactionValue : $26,246,802,400.00$238,458,400.00Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.#5 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).#6 Price is the closing price of Pfizer common stock on February 23, 2024.
-
F845,180,000 Shares After TransactionValue : $23,132,576,600.00$2,745,484,700.00Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.#5 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).#6 Price is the closing price of Pfizer common stock on February 23, 2024.
-
F815,260,000 Shares After TransactionValue : $22,631,617,600.00$830,579,200.00Transaction Date : 02/25/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.#5 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).#6 Price is the closing price of Pfizer common stock on February 23, 2024.
-
F754,630,000 Shares After TransactionValue : $20,510,843,400.00$1,647,923,400.00Transaction Date : 02/26/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.#5 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).#6 Price is the closing price of Pfizer common stock on February 23, 2024.